Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Should Value Investors Buy Manulife Financial Corp (MFC) Stock?
Should Value Investors Buy Manulife Financial Corp (MFC) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

COF to Take Full Control of Travel Platform With Hopper Tech Deal
COF to Take Full Control of Travel Platform With Hopper Tech Deal

Capital One Financial Corporation COF is reshaping its travel business by striking a deal with Hopper to acquire the underlying technology, supplier ties and around 150 employees who helped build

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates
MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates

MARKER THERAPEUTICS, INC. (MRKR) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.42 per share a year ago

Is CarMax (KMX) Stock Undervalued Right Now?
Is CarMax (KMX) Stock Undervalued Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Are Investors Undervaluing Centerra Gold (CGAU) Right Now?
Are Investors Undervaluing Centerra Gold (CGAU) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Is Adecoagro (AGRO) Outperforming Other Consumer Staples Stocks This Year?
Is Adecoagro (AGRO) Outperforming Other Consumer Staples Stocks This Year?

The Consumer Staples group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Adecoagro (AGRO) been one of those stocks this

AEVA's CityOS Turns Traffic Smart With AI and LiDAR Tech
AEVA's CityOS Turns Traffic Smart With AI and LiDAR Tech

Aeva Technologies AEVA has introduced CityOS, an AI-powered traffic platform designed to deliver real-time insights. Built on NVIDIA’s NVDA AGX Orin, the system aims to make intersections and

Looking for a Growth Stock? 3 Reasons Why Astec Industries (ASTE) is a Solid Choice
Looking for a Growth Stock? 3 Reasons Why Astec Industries (ASTE) is a Solid Choice

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Here is Why Growth Investors Should Buy JBT (JBTM) Now
Here is Why Growth Investors Should Buy JBT (JBTM) Now

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates

Sol-Gel Technologies Ltd. (SLGL) came out with a quarterly loss of $1.07 per share versus the Zacks Consensus Estimate of $0.39. This compares to a loss of $2.1 per share a year ago. These figures

Should Value Investors Buy Eldorado Gold (EGO) Stock?
Should Value Investors Buy Eldorado Gold (EGO) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Are Investors Undervaluing Blackbaud (BLKB) Right Now?
Are Investors Undervaluing Blackbaud (BLKB) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

New Strong Sell Stocks for March 23rd
New Strong Sell Stocks for March 23rd

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

BitFuFu Inc. FUFU is dedicated to fostering a secure, compliant, and transparent blockchain infrastructure by providing a

Should Value Investors Buy Hennes & Mauritz (HNNMY) Stock?
Should Value Investors Buy Hennes & Mauritz (HNNMY) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Are Investors Undervaluing BGC Group, Inc. (BGC) Right Now?
Are Investors Undervaluing BGC Group, Inc. (BGC) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

New Strong Sell Stocks for March 24th: https://staticx-tuner.zacks.com/images/articles/main/f6/146115.webp
New Strong Sell Stocks for March 24th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Cohu COHU is a leading supplier of semiconductor test and inspection handlers, micro-electro mechanical system (MEMS) test

Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.03. This compares to a loss of $0.06 per share a year ago. These figures

Is GDS Holdings (GDS) Stock Outpacing Its Business Services Peers This Year?
Is GDS Holdings (GDS) Stock Outpacing Its Business Services Peers This Year?

The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has GDS Holdings (GDS) been one of those stocks this

LENZ Therapeutics, Inc. (LENZ) Reports Q4 Loss, Misses Revenue Estimates
LENZ Therapeutics, Inc. (LENZ) Reports Q4 Loss, Misses Revenue Estimates

LENZ Therapeutics, Inc. (LENZ) came out with a quarterly loss of $1.16 per share versus the Zacks Consensus Estimate of a loss of $0.91. This compares to a loss of $0.46 per share a year ago. These

Should Value Investors Buy Magnite (MGNI) Stock?
Should Value Investors Buy Magnite (MGNI) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With